← Leaderboards
Hisataka Kobayashi
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsAntibodiesSensitivity And SpecificityImaging ModalityTissuesImaging ProbeTherapeutic EffectAreaCell TypeChemotherapyCancer CellCancer CenterCancer ImagingDiagnosisBiologicalCell MembraneAppearanceContrast MediaBiodistributionCell KillingCell SurfaceCollaborationsDesign
Grant awards (26)
Cancer-cell specific therapy: photo-immunotherapy$1,736,158
ZIA · FY2025 · CA · contact PI
Activatable molecular cancer imaging probe$192,907
ZIA · FY2025 · CA · contact PI
Cancer-cell specific therapy: photo-immunotherapy$1,628,150
ZIA · FY2024 · CA · contact PI
Activatable molecular cancer imaging probe$180,905
ZIA · FY2024 · CA · contact PI
Cancer-cell specific therapy: photo-immunotherapy$1,611,216
ZIA · FY2023 · CA · contact PI
Activatable molecular cancer imaging probe$179,024
ZIA · FY2023 · CA · contact PI
Cancer-cell specific therapy: photo-immunotherapy$1,387,661
ZIA · FY2022 · CA · contact PI
Activatable molecular cancer imaging probe$154,185
ZIA · FY2022 · CA · contact PI
Cancer-cell specific therapy: photo-immunotherapy$1,555,754
ZIA · FY2021 · CA · contact PI
Activatable molecular cancer imaging probe$172,862
ZIA · FY2021 · CA · contact PI
Cancer-cell specific therapy: photo-immunotherapy$1,575,941
ZIA · FY2020 · CA · contact PI
Activatable molecular cancer imaging probe$175,104
ZIA · FY2020 · CA · contact PI
Cancer-cell specific therapy: photo-immunotherapy$1,466,429
ZIA · FY2019 · CA · contact PI
Activatable molecular cancer imaging probe$162,937
ZIA · FY2019 · CA · contact PI
Cancer-cell specific therapy: photo-immunotherapy$1,006,345
ZIA · FY2018 · CA · contact PI
Activatable molecular cancer imaging probe$177,590
ZIA · FY2018 · CA · contact PI
Cancer-cell specific therapy: photo-immunotherapy$1,071,513
ZIA · FY2017 · CA · contact PI
Activatable molecular cancer imaging probe$357,172
ZIA · FY2017 · CA · contact PI
Cancer-cell specific therapy: photo-immunotherapy$1,332,032
ZIA · FY2016 · CA · contact PI
Activatable molecular cancer imaging probe$444,010
ZIA · FY2016 · CA · contact PI
Cancer-cell specific therapy: photo-immunotherapy$476,718
ZIA · FY2015 · CA · contact PI
Activatable molecular cancer imaging probe$158,906
ZIA · FY2015 · CA · contact PI
Cancer-cell specific therapy: photo-immunotherapy$359,358
ZIA · FY2014 · CA · contact PI
Activatable molecular cancer imaging probe$154,011
ZIA · FY2014 · CA · contact PI
Cancer-cell specific therapy: photo-immunotherapy$337,559
ZIA · FY2013 · CA · contact PI
Activatable molecular cancer imaging probe$144,669
ZIA · FY2013 · CA · contact PI